Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2007 (2007), Article ID 91236, 7 pages
http://dx.doi.org/10.1155/2007/91236
Review Article

Role of Apolipoprotein E in Anxiety

Departments of Behavioral Neuroscience and Neurology, Division of Neuroscience, Oregon National Primate Research Center (ONPRC), Oregon Health & Science University, L470, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA

Received 20 November 2006; Accepted 7 February 2007

Academic Editor: Patrice Venault

Copyright © 2007 Jacob Raber. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. V. Rabins, N. L. Mace, and M. J. Lucas, “The impact of dementia on the family,” Journal of the American Medical Association, vol. 248, no. 3, pp. 333–335, 1982. View at Publisher · View at Google Scholar
  2. D. W. Gilley, R. S. Wilson, D. A. Bennett, B. A. Bernard, and J. H. Fox, “Predictors of behavioral disturbance in Alzheimer's disease,” Journals of Gerontology, vol. 46, no. 6, pp. P362–P371, 1991. View at Google Scholar
  3. C. M. Morris, H. M. Massey, R. Benjamin et al., “Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias,” Journal of Neural Transmission, Supplementum, no. 47, pp. 205–218, 1996. View at Google Scholar
  4. L. B. Barclay, A. Zemcov, J. P. Blass, and F. H. McDowell, “Factor associated with duration of survival in Alzheimer's disease,” Biological Psychiatry, vol. 20, no. 1, pp. 86–93, 1985. View at Publisher · View at Google Scholar
  5. R. J. Martin, L. P. Gwyther, and P. J. Whitehouse, “Special care unit research: ethical issues,” Alzheimer Disease and Associated Disorders, vol. 8, 1, pp. S360–S367, 1994. View at Google Scholar
  6. P. W. Burvill, W. D. Hall, H. G. Stampfer, and J. P. Emmerson, “The prognosis of depression in old age,” British Journal of Psychiatry, vol. 158, pp. 64–71, 1991. View at Google Scholar
  7. V. R. Porter, W. G. Buxton, L. A. Fairbanks et al., “Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 15, no. 2, pp. 180–186, 2003. View at Publisher · View at Google Scholar
  8. A. Gustavson and J. Cummings, “Assessment and treatment of neuropsychiatric symptoms in Alzheimer's disease,” in Current Clinical Neurology, Alzheimer's Disease; A Physician's Guide for Pratical Management, R. W. Richter and B. Z. Richer, Eds., pp. 371–385, Humana Press Totowa, Totowa, NJ, USA, 2004. View at Google Scholar
  9. M. de Toledo, F. Bermejo-Pareja, S. Vega-Quiroga, and D. Munoz-Garcia, “Behavioural disorders in Alzheimer's disease. Data from a populational study,” Revista de Neurologia, vol. 38, no. 10, pp. 901–905, 2004. View at Google Scholar
  10. S. M. McCurry, L. E. Gibbons, R. G. Logsdon, and L. Teri, “Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease,” Journal of Gerontological Nursing, vol. 30, no. 1, pp. 12–20, 2004. View at Google Scholar
  11. R. W. Mahley, “Apolipoprotein E: cholesterol transport protein with expanding role in cell biology,” Science, vol. 240, no. 4852, pp. 622–630, 1988. View at Publisher · View at Google Scholar
  12. L. A. Farrer, L. A. Cupples, J. L. Haines et al., “Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis,” Journal of the American Medical Association, vol. 278, no. 16, pp. 1349–1356, 1997. View at Publisher · View at Google Scholar
  13. J. Raber, S. F. Akana, S. Bhatnagar, M. F. Dallman, D. Wong, and L. Mucke, “Hypothalamic-pituitary-adrenal dysfunction in Apoe/ mice: possible role in behavioral and metabolic alterations,” Journal of Neuroscience, vol. 20, no. 5, pp. 2064–2071, 2000. View at Google Scholar
  14. M. M. Prack, M. Nicosia, D. L. Williams, and J. Gwynne, “Relationship between apolipoprotein E mRNA expression and tissue cholestorol content in rat adrenal gland,” Journal of Lipid Research, vol. 32, no. 10, pp. 1611–1618, 1991. View at Google Scholar
  15. M. Nicosia, M. M. Prack, and D. L. Williams, “Differential regulation of apolipoprotein-E messenger RNA in zona fasciculata cells of rat adrenal gland determined by in situ hybridization,” Molecular Endocrinology, vol. 6, no. 2, pp. 288–298, 1992. View at Publisher · View at Google Scholar
  16. M. Imaizumi and K. Onodera, “The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice,” Life Sciences, vol. 53, no. 22, pp. 1675–1683, 1993. View at Publisher · View at Google Scholar
  17. G. Bongers, R. Leurs, J. Robertson, and J. Raber, “Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe/ mice,” Neuropsychopharmacology, vol. 29, no. 3, pp. 441–449, 2004. View at Publisher · View at Google Scholar
  18. C. Rampon, Y.-P. Tang, J. Goodhouse, E. Shimizu, M. Kyin, and J. Z. Tsien, “Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice,” Nature Neuroscience, vol. 3, no. 3, pp. 238–244, 2000. View at Publisher · View at Google Scholar
  19. J. Raber, G. Bongers, A. LeFevour, M. Buttini, and L. Mucke, “Androgens protect against apolipoprotein E4-induced cognitive deficits,” Journal of Neuroscience, vol. 22, no. 12, pp. 5204–5209, 2002. View at Google Scholar
  20. T. Oda, N. Morikawa, Y. Saito, Y. Masuho, and S.-I. Matsumoto, “Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes,” Journal of Biological Chemistry, vol. 275, no. 47, pp. 36781–36786, 2000. View at Publisher · View at Google Scholar
  21. M. Yuzurihara, Y. Ikarashi, A. Ishige, H. Sasaki, H. Kuribara, and Y. Maruyama, “Effects of drugs acting as histamine releasers or histamine receptor blockers on an experimental anxiety model in mice,” Pharmacology Biochemistry and Behavior, vol. 67, no. 1, pp. 145–150, 2000. View at Publisher · View at Google Scholar
  22. M. Imaizumi, S. Miyazaki, and K. Onodera, “Effects of betahistine, a histamine H1 agonist and H3 antagonist, in a light/dark test in mice,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 18, no. 1, pp. 19–24, 1996. View at Google Scholar
  23. J. Raber, “Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation: from obesity to memory deficits,” Molecular Neurobiology, vol. 18, no. 1, pp. 1–22, 1998. View at Google Scholar
  24. L. K. Heisler, H.-M. Chu, T. J. Brennan et al., “Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 15049–15054, 1998. View at Publisher · View at Google Scholar
  25. J. Robertson, J. Curley, J. Kaye, J. Quinn, T. Pfankuch, and J. Raber, “apoE isoforms and measures of anxiety in probable AD patients and Apoe/ mice,” Neurobiology of Aging, vol. 26, no. 5, pp. 637–643, 2005. View at Publisher · View at Google Scholar
  26. J. Balldin, C. G. Gottfries, I. Karlsson, G. Lindstedt, G. Langstrom, and J. Walinder, “Dexamethasone suppression test and serum prolactin in dementia disorders,” British Journal of Psychiatry, vol. 143, no. 3, pp. 277–281, 1983. View at Google Scholar
  27. L. Groenink, A. Dirks, P. M. Verdouw et al., “HPA axis dysregulation in mice overexpressing corticotropin releasing hormone,” Biological Psychiatry, vol. 51, no. 11, pp. 875–881, 2002. View at Publisher · View at Google Scholar
  28. M. J. de Leon, T. McRae, H. Rusinek et al., “Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 10, pp. 3251–3259, 1997. View at Publisher · View at Google Scholar
  29. E. W. P. Nijhuis, F. Oostervink, B. Hinloopen, J. Rozing, and L. Nagelkerken, “Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia,” Brain, Behavior, and Immunity, vol. 10, no. 2, pp. 115–125, 1996. View at Publisher · View at Google Scholar
  30. T. den Heijer, M. Oudkerk, L. J. Launer, C. M. van Duijn, A. Hofman, and M. M. B. Breteler, “Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes,” Neurology, vol. 59, no. 5, pp. 746–748, 2002. View at Google Scholar
  31. M. Lehtovirta, H. Soininen, M. P. Laakso et al., “SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E ε4 allele,” Journal of Neurology Neurosurgery and Psychiatry, vol. 60, no. 6, pp. 644–649, 1996. View at Google Scholar
  32. G. McKann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Serives Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Google Scholar
  33. L. Flicker, R. N. Martins, J. Thomas et al., “Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men,” Journal of Alzheimer's Disease, vol. 6, no. 3, pp. 329–336, 2004. View at Google Scholar
  34. R. Stewart, C. Russ, M. Richards, C. Brayne, S. Lovestone, and A. Mann, “Depression, APOE genotype and subjective memory impairment: a cross-sectional study in an African-Caribbean population,” Psychological Medicine, vol. 31, no. 3, pp. 431–440, 2001. View at Google Scholar
  35. G. Ramachandran, K. Marder, M. Tang et al., “A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease,” Neurology, vol. 47, no. 1, pp. 256–259, 1996. View at Google Scholar
  36. M. Mauricio, R. O'Hara, J. A. Yesavage et al., “A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults,” American Journal of Geriatric Psychiatry, vol. 8, no. 3, pp. 196–200, 2000. View at Publisher · View at Google Scholar
  37. D. G. Harwood, W. W. Barker, R. L. Ownby, P. St. George-Hyslop, and R. Duara, “Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease,” American Journal of Geriatric Psychiatry, vol. 7, no. 2, pp. 119–123, 1999. View at Google Scholar
  38. R. J. Caselli, E. M. Reiman, D. Osborne et al., “Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele,” Neurology, vol. 62, no. 11, pp. 1990–1995, 2004. View at Google Scholar
  39. M. L. Levy, J. L. Cummings, L. A. Fairbanks, D. L. Sultzer, and G. W. Small, “Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease,” Biological Psychiatry, vol. 45, no. 4, pp. 422–425, 1999. View at Publisher · View at Google Scholar
  40. N. Scarmeas, J. Brandt, M. Albert et al., “Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease,” Neurology, vol. 58, no. 8, pp. 1182–1188, 2002. View at Google Scholar